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Primary biliary cirrhosis (PBC) is considered an autoimmune disease characterized by destruction of small intrahepatic 
bile ducts by lymphocytes. Altered functions of these lymphocytes might reflect an abnormal immune response leading 
to tissue damage. We investigated lymphokine secretion by mitogen-stimulated T lymphocytes from the liver biopsies 
of patients with PBC and for comparison also peripheral blood. In PBC, diminished synthesis of lymphotoxin (TNFP), 
tumor necrosis factor (TNFa) and interferon-y (IFIVy) was found both in T-cell lines from liver tissue and in peripheral 
blood. The reduction was most prominent for TNFP in early histological stages of PBC, and appeared to be a stable 
phenomenon when T cells were tested after long-term tissue culture. Analysis of mRNA levels indicates a possible link 
between reduced TNFP production and a defect in interleukin-2 transcription. The data suggest that diminished 
lymphokine production in patients with PBC may play ;In important role in the immanopathogenesis of this disease. 
Primary biliary cirrhosis (PBC) is a chronic and pro- 
gressive nonsuppurative inflammation of the intrahepatic 
bile ducts, possibly caused by autoimmune reactions. 
Although much progress has been made in unravelling 
the autoantibody response and the nature of associated 
autoantigens, the etiology and pathogenesis of PBC are 
still unknown. Activated T lymphocytes infiltrating af- 
fected bile ducts are the histological hallmark of this 
disease. Thus, the contribution of T lymphocytes may 
play a pivotal role in the induction and progression of 
PBC. 
Lymphokir;es are secreted by activated T lymphocytes 
as essential soluble transmitters of cell-to-cell communi- 
cation in the immune system. They exert potent immu- 
noregulatory functions, and control local and systemic 
immune responses. Moreover, recent work suggests that 
local lymphokine production may be necessary for the 
induction of anti-self T lymphocytes (1). In order to 
investigate functions of T lymphocytes at the site of in- 
flammation, we established T-cell lines both from liver 
biopsies and from the peripheral blood of patients with 
PBC and measured the production of lymphotoxin 
(TNFP), tumor necrosis factor (TNFa) and interferon y 
(IFNy) upon stimulation with mitogen. 
Patients 
Peripheral blood and liver tissue specimens from 35 
female and four male patients with primary biliary cir- 
rhosis, aged 32-64 years, were included in this study. 
Diagnosis of PBC was established by accepted clinical, 
biochemical and histological criteria. All patients had 
significant itrer; of antimitochondrial antibodies. Histo- 
logically, 20 patients had early disease (stages I or II 
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according to Scheuer (2)), and 19 patients had advanced 
disease (stages III or IV). Sixteen healthy women and 15 
healthy man aged 24 to 66 years volunteered to give 
blood for control experiments. Eight patients with acute 
and 41 patients with chronic hepatitis B, 16 patients with 
chronic non-A, non-B hepatitis, and ten patients with 
primary sclerosing cholangitis (PSC) were studied as dis- 
ease controls. 
Preparation of T cells 
Peripheral blood mononuclear cells (PBMC) were pu- 
rified from heparinized blood on a Ficoll-Paquc density 
gradient (Pharmacia, Sweden) (3). T lymphocytes were 
propagated as T-cell lines in RPM1 1640 medium (2% 
L-glutamine, 1% penicillin/streptomycin and 10% AB se- 
rum) in the presence of lo4 irradiated (4000 rad) autol- 
ogous feeder cells, 0.125 &ml phytohemagglutinin 
(PHA; Sigma, ERG.) and 20 U/ml human recombinant 
interleukin-2 (IL2; kindly provided by Dr. F. Sinigaglia, 
Base1 Institute for Immunology; Hoffmann-La Roche, 
Switzerland). By a similar technique T-cell lines were 
generated from small fragments of liver specimens ob- 
tained by the Menghini technique, as described in detail 
previously (4). All liver biopsies were taken for diagnos- 
tic reasons not related to this study. 
Phenotypes of T cells were analyzed on a fluorescence 
activated cell sorter (FACSCAN, Becton Dickinson, 
U.S.A.) by indirect immunofluorescence (fluoroisothio- 
cyanate-labeled goat-anti-mouse antiserum, Medac, 
Hamburg, F.R.G.) with monoclonal antibodies M-T310 
(antiXD4), M-T151 (antXD4) M-T811 (anti-CDS) and 
M-T122 (anti-CCgj (kindly provided by Dr. E.P. Rieber, 
Munich). Double-staining of cells was performed with 
phycoerythrin-coupled monoclonal antibodies 2H4 (anti- 
CD45RO) and 4B4 (anti-CD39) (Coulter Electronics, 
U.S.A.). 
Stimulation protocol 
T-cell lines were left for 10 days without adding fresh 
feeder cells before the stimulation experiments. Lym- 
phokine production was induced by the addition of 2 
&ml PHA (Sigma, F.R.G.) to 2*106 T lymphocytes in 1 
ml serum free RPM1 1640 medium. Control experiments 
without PHA were always run in parallel to check for 
inadvertant activation of T cells by the medium. To en- 
sure that T-cell lines were free of functional macro- 
phages, control stimulations with 1 &ml lipopolysaccha- 
ride (LPS; Escherichia coli serotype 055:B5, Sigma, 
F.R.G.) (5) were included. Based on our results con- 
cerning the kinetics of TNFa@ and IFNy production 
upon mitogen induction, supernatants from stimulated 
T-cell lines as well as from freshly isolated PBMC were 
collected 3 days after PHA stimulation for determination 
of TNFB, TNFa and IFNy. As internal stimulation con- 
trol T lymphocytes of two previously tested individuals 
were included in each analysis, resulting in a reproduc- 
ible lymphokine response. For costimulation experiments 
recombinant human interleukin-4 (IL4), interleukin-6 
(IL6) and the monoclonal IL2 antibody DMS-1 were 
purchased from IC Chemikalien, Munich. 
Determination of lymphokines 
Interferon-y (IFNr), tumor necrosis factor (TNFa) and 
lymphotoxin (TNF/3) were measured by ELISA as de- 
scribed previously (6). Monoclonal antibodies clone 69 
(anti-IFNy), 199-1 (anti-TNFa), and 9B9 (anti-TNFP) 
were used as first layer bound to polystyrene microtitre 
plates. One hundred ~1 (50 ~1 for the IFNy test) of an 
appropriately diluted test sample or recombinant lym- 
phokine as external standard were incubated for 24 h at 
4°C on the precoated plates. Bound lymphokine was 
detected by a horseradish-peroxidase-coupled mono- 
clonal anti-IFNy antibody (clone 123) or by biotinylated 
antibodies against TNFa (195-8) and TNFP (polyclonal 
antiserum) followed by incubation with peroxidase- 
coupled streptavidin (BRL, U.S.A.). Tetramethylbenzi- 
dine (Serva, F.R.G.) in acetate/citric acid buffer (pH 4.9) 
was used as chromogenic substrate. Extinctions were 
read in an ELISA spectrophotometer at 450 nm (SLT, 
Austria), Results were determined as means from double 
determinations of at least two subsequent serial sample 
dilution steps. Reagents for determinations of IFNy were 
kindly provided by Hoffmann-La Roche (Dr. H. Gal- 
lati), Switzerland. Sensitivity was 10 pg/ml for TNFa or 
TNF/3 and 10 U/ml for IFNy. ELISAs were not crossre- 
active below 100 @ml. 
For RNA isolation 8a106 cells were harvested from 
parallel stimulation experiments with the same cell prep- 
arations. 10 &ml cycloheximide (Sigma, F.R.G.) was 
added 3 h prior to harvesting of cells. Cells were lysed in 
guanidium isothiocyanate buffer and sonified for 5 s to 
achieve breakage of DNA (Branson cell disrupton B15 
with microtip, U.S.A.). RNA was prepared by CsCl 
gradient centrifugation, fractionated by formaldehyde/ 
agarose gel electrophoresis and blotted to Hybond N 
membranes (Amersham, F.R.G.). A genomic 625 bp 
HindIWXhoI fragment spanning exon 4/3’ UT was used 
as specific probe for TNFa. The 600 bp PstUPvuII TNFp- 
specific fragment was prepared of the corresponding 
TNFP region. IL2 was probed with a 800 bp PstI cDNA 
fragment (7). Fragments were radioIabeled according to 
Feinberg and Vogelstein (8). Hybridization and washing 
of the filters was performed with 5-106 cpmlml according 
to Church and Gilbert (9). 
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TABLE 1 
Production of lymphotoxin (TNFB), tumor necrosis factor (TNFa) and interferon-y (IFNy) by PHA-stimuiat 
inflammatory liver disease 
ed T-ce!! lines in patients with 
Lymphotoxin (pglml) Tumor necrosis factor 
(pg/mi) 
Interferon-y (U/ml) 
T-cell lines from liver biopsies 
PBC (early) 1810 + 636 (9)+* 793 + 162 (9)d.* 42 + 14 (6)’ 
PBC (late) 2714 f 837 (ll)b 1463 + 461 (11) 228 rt 100 (4) 
H-B (chronic) 475.5 f 714 (23) 4514 + 810 (23) 194 + 33 (14) 
HNANB 2713 + 617 (10) 2678 f 734 (10) 236 + 96 (4) 
PSC 6625 f 2157 (4) 2730 + 677 (4) 99 + 6 (3) 
T-cell lines from peripheral blood 
PBC (early) 925 +- 914 (4)f.* 1466 f 793 (4) 134 f 50 (4) 
PBC (late) 5804 + 2173 (14) 2237 + 682 (14) 97 + 24 (12)s 
H-B (acute) 6253 & 2802 (6) 3150 + 325 (6) 167 + 43 (3) 
H-B (chronic) 6808 + 1045 (11) 4813 + 125 (11) 74 + 23 (8) 
HNANB 5675 f 2630 (11) 1956 f 102 (11) 262 + 13 (3) 
PSC 13719 + 7359 (4) 2630 + 115 (4) 201 + 17 (2) 
Controls 12272 f 2536 (15) 2370 f 448 (15) 294 + 70 (13) 
Protein levels (mean f SE.) of lymphotoxin (TNF/3), tumor necrosis facior (TNFcr) and interferon-y (IFNy) in supernatants of PI-IA stimu- 
lated T-cell lines derived from liver tissue and peripheral blood. All culture supernatant (1 ml/well) was removed from 2.106 cells on day 3 
after the addition of 2 pg PHA and frozen at -70°C until analysis by ELISA. The study groups consisted of patients with early (histological 
stages I and II according to (2)) and late (histological stages III and IV according to (2)) primary biliary cirrhosis (PBC), acute and chronic 
hepatitis B (H-B), chronic non-A, non-B hepatitis (HNANB), primary sclerosing cholangitis (PSC) and healthy controls. For ethical reasons 
only T-cell lines from peripheral blood were available in healthy controls and patiens with acute hepatitis B. The number of cell lines tested 
within each group is given in brackets. Results of the Kruskal Wallis test are indicated by * for p < 0.05 and ** for p < O.Oi. Differences be- 
tween groups were evaluated by the Mann-Whitney test as: *early PBC vs. chronic H-B: p = 0.0160, vs. PSC: p = 0.0308; blate PBC vs. 
chronic H-B: p = 0.0489, vs. PSC: p = 0.0265; ‘early PBC vs. controls: p = 0.0051, vs. acute H-B: p = 0.0330, vs. chronic H-B: p = 0.0098; 
dearly PBC vs. chronic H-B: p = 0.0053, vs. HNANB: p = 0.0549. vs. PSC: p = 0.0055: ?ate PBC vs. chronic H-B: p = 0.0489; feariy PBC 
vs. chronic H-B: p = 0.0065, vs. PSC: p = 0.0196; glate PBC vs. controls: p = 0.0462. 
Statistics 
Quantitative data are expressed as mean f S.E. The 
H-test of Kruskal and Wallis was used to study whether 
the various patient groups originated in a common pop- 
ulation. In addition, patient groups were compared in 
pairs by the Mann-Whitney test. p < 0.05 (two-sided) 
was considered to indicate statistically significant differ- 
ences. 
es& 
Reduced lymphokine production in PBC 
The cytokines TNFP, TNFa and IFNy could not be 
detected in unstimulated supematants of T cells. Accord- 
ing to our stimulation protocol, TNF/?, TNFa and IFNy 
reached maximum protein levels 2-4 days after the ad- 
dition of the mitogen. Thereafter protein levels declined. 
The lymphokine production was analyzed in three 
T-cell compartments: in T-cell lines derived from liver 
biopsies and peripheral blood and in freshly isolated 
PBMC. In patients with PBC the activation 0: T-cell 
lines by mitogen resulted in lower production of TNFP, 
TNFa and IFNy compared to healthy controls and pa- 
tients with acute and chronic hepatitis B, chronic non-A, 
non-B hepatitis and sclerosing cholangitis (Table 1). This 
result was obtained both with T-cell lines derived from 
peripheral blood or from liver biopsies. Moreover, a 
lower lymphokine production could be observed in pa- 
tients with PBC, when TNFP, TNFa and IFNy were 
measured at each interval from days 2 to 6 after mitogen 
addition. Reduced lymphokine production by T lympho- 
cytes from patients with PBC was a persistent phenom- 
enon when T-cell lines were tested after longer periods 
of tissue culture (up to 6 weeks tested). Impaired lym- 
phokine synthesis in PBC was detected irrespective of 
the dose of applied mitogen (0.5-8 &ml PHA per lo6 
cells). Generally the T-cell lines consisted of 63-72% 
CD4+ and 31-33% CDS+ lymphocytes. Furthermore, 
differences in lymphokine induction could not be attrib- 
uted to interindividual alterations in the phenotypic com- 
position of T-cell preparations. Moreover, lymphokine 
formation was not related to the degree of cholestasis of 
PBC as judged by serum bilimbin and alkaline phos- 
phatase levels. Interestingly, lymphokine production ap- 
peared to be particularly, poor in patients with early 
histological stages of the disease (stages I or II). This 
observation was confirmed by stimulation experiments of 
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Fig. 1. TNFa and TNFB production (mean + S.E.) by freshly 
isolated PBMC obtained from patients with primary biliary cirrhosis 
(PBC), acute and chronic hepatitis B (AHB and CHB, respec- 
tively), chronic non-A, non-B hepatitis (HNANB), primary scle- 
rosing cholangitis (PSC) and healthy controls (CON). Early PBC 
refers to histological stages I and II and late disease to histological 
stages III and IV (according to (2)). The number of patients studied 
in each group is given as ‘N = . . .’ between the two graphs. The 
stimulation procedure was identical to that used for T cell lines (see 
Material and Methods). **Indicates a level of significance p < 0.01 
as calculated by the Krusk.&Wallis test. Differences between groups 
were evaluated as follows (Mann-Whitney test): (i) TNFa: early 
PBC vs. CHB p < 0.0001, early PBC vs. HNANB p = 0.0020; (ii) 
TNFB: early PBC vs. controls p = 0.0004, vs. AHB 0.0252, vs. 
CHB p = 0.0003, vs. HNANB p = 0.0204, vs. PSC p = 0.0072 and 
late PBC vs. controls p = 0.0184. 
PBMC in a large collective resulting in a dramatically 
reduced TNFcz and TNF,S production upon mitogen in- 
duction in patients with early PBC (Fig. 1). 
Modulation 0; TNFF production by interleukin-2 
In PBC reduced lymphokine production in T cells of 
all three compartments was most prominent for TNFB. 
Therefore, the synthesis of this lymphokine was further 
analyzed at the mRNA level. TNF/3 protein levels were 
found to correlate closely to the amount of TNFB mRNA 
transcripts when analyzed in parallel by stimulation of 
PBMC (Fig. 2). Moreover, TNFfi mRNA and protein 
appeared to be correlated also with the amount of IL2 
mRNA. The association between low IL2 and a reduced 
TNF/l production was further demonstrated by dose- 
dependent increases of TNF/3 protein when exogenous 
recombinant IL2 was added to the lectin stimulation (Fig. 
3). Moreover, PBMC of PBC patients produced the same 
amounts of TNFP as PBMC of controls when induced in 
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Fig. 2. TNFB protein (pg/ml) and mRNA levels in PBMC from four 
healthy subjects (WM, EW, WW, UB) after PI-IA stimulation in 
correlation to the IL2 production. The TNF@ protein synthesis was 
determined in 1 ml culture supernatent (2*106 cells) on days 0, 1, 2 
and 3 of incubation with PHA. The amount of TNFB mRNA (1.3 
kb) and IL2 mRNA (0.9 kb) was anaIyzed after 12 and 24 h, 
respectively, with (+) and without (-) PHA by hybridization both 
with a TNF#) and IL2 specific probe in a Northern blot analysis of 
8-10 pg total RNA prepared from parallel stimulation experiments. 
Cycloheximide (10 pcglml) was added 3 h prior to harvesting of cells. 
Cycloheximide treatment increased IL2 and TNF/l mRNA signals, 
but did not change the relative character of mRNA inducibility. 
The ethidium bromide staining of the 28S ribosomal RNA is in- 
cluded as control for the amount of RNA loaded per lane. IL2 
mRNA synthesis preceded TNF/3 mRNA signals. The intensities of 
the hybridization signals for both lymphokines correlated with each 
other and with the amount of TNF#) protein. 
the presence of 200 U/ml recombinant IL2. No compa- 
rable reconstitution of the TNFP response was achieved 
by the addition of IL4, IL6, TNFa or IFNy to PBMC. 
Thus, following mitogen stimulation IL2 appears to be a 
major modulating factor for TNFP production. In super- 
natants obtained from T-cell lines or PBMC stimulated 
with 2 pg PHA, IL2 protein levels could not be measured 
by ELISA. 
Discussion 
Damage of intrahepatic bile ducts by activated T cells 
is assumed to be a key event in the pathogenesis of PBC 
(10). Since the antigenic determinants in PBC recognized 
by infiltrating T cells have not yet been identified, lectin 
stimulation by-passing antigen recognition has largely 
been used for studies of T-cell activation. This paper 
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Fig. 3. Stimulation of TNFfi production by recombinant IL2. Left- 
hand side: TNF/3 production (mean + SE.) in correlation to ex- 
ogenous IL2. Increasing amounts (5-200 U/ml) of recombinant IL2 
were added to 2.10’ PBMC from patients with PEC (open circles, 
n = 7; black circles, n = 15) and healthy controls (open squares, n 
= 4; black squares, n = 7) during PHA stimulation. TNF/l was 
determined by ELISA in supernatants harvested 3 days after stim- 
ulation. Right-hand side: TNF/3 production (mean + S.E.) in the 
presence of anti-IL2 antibody (a-IL2 Ab). Two to ten pg./ml of the 
neutralizing monoclonal antibody DMS-1 were added to 2.106 PHA- 
stimulated (3 days) PBMC from patients with PBC (open circles, n 
= 5; black circles, n = 15) and healthy subjects (open squares, n = 
3; black squares, n = 7). in the range used, DMS-1 was not 
crossreactive with TNF/?. 
describes a defect in mitogen-induced production of 
TNF/3, TNFa and IFNy by T lymphocytes specifically 
from patients with PBC. Reduced lymphokine secretion 
could be observed both in T-cell lines derived from pe- 
ripheral blood and more importantly in T-cell lines from 
affected liver tissue. Several groups, including our own, 
have characterized T-cell lines from liver biopsies in PBC 
demonstrating that, at least phenotypically, liver-derived 
T-cell lines correspond to portal lymphocellular infiltrates 
(4,11,12). Provided that these T-cell lines also reflect the 
functional state of portal T lymphocytes, the results pre- 
sented here indicate that lymphokine secretion and cell 
activation may be impaired in T lymphocytes as the site 
of tissue destruction. This reduced functional capacity is 
a stable characteristic 3f T cells in PBC, since defective 
lymphokine secretion was present in liver-derived T-cell 
lines kept in tissue culture for various periods of time (up 
to 6 weeks). 
Impaired production of TNF& TNFa and IFNy was 
particularly low in patients with early histological stages 
(stages I and II) of PBC. Inflammatory bile duct destruc- 
tion mediated by immunological mechanisms is assumed 
to occur predominantly in the early stages of PBC, while 
fibrosis and cirrhosis and their consequences dominate 
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the pathogenetic events in advanced PBC (12). Thus, it 
is likely that reduced production of TNFP, ?WFa and 
IFW may reflect the immunologically active stages of 
WX rather than the consequences of cholestasis or cir- 
rhosis. Although sequential testing of lymphokine syn- 
thesis has not yet been performed during the course of 
disease in individual PBC patients, the smaller decrease 
in lymphokine production in patients with advanced dis- 
ease suggests that the apparent defect in mitogen in- 
duced lymphokine generation may be a transient phe- 
nomenon. 
Reduced lymphokine production in PBC was most 
evident in the TNFP response, and was also detected at 
the level of mRNA. Low amounts of TNF/3 mRNA al- 
ways corresponded with reduced TNFF secretion. More- 
over, the amount of IL2 mRNA correlated with TN?@ 
mRNA and TNF/l protein levels in healthy controls as 
well in PBC patients. Reduced IL2 activity in PBC has 
been reported by Sasena and his co-workers, when 
mitogen-stimulated lymphocytes from peripheral blood 
were tested in a bio-assay (14). Our results confirm the 
previous observatious and demonstrate a tight linkage 
between the induction of IL2 and TNFfi transcription 
and TNF/3 production. This linkage between IL2 and 
TNF/3 production is further supported by the observation 
that addition of exogenous recombinant IL2 to PBMC of 
patients with PBC could specifically reconstitute TNF/3 
production in a dose-dependent fashion. Other cytokines 
like IL4, IL.6 or IFNy, which can also influence TNF,!? 
production (15,16), showed II~ comparable nhancement 
of TNFP synthesis. These results are in agreement with 
findings by Kasid and co-workers (17), who in a similar 
stimulation experiment identified IL2 and IL1 as major 
modulators of TNF/3, TNFa, and IFNy production in 
human PBMC. However, it is not clear whether reduced 
generation of TNF/3 and other lymphokines can be fully 
attributed to low IL2 activity in PBC. Allelic differences 
of the TNFfi gene linked with a differential TNFP re- 
sponse cannot account for the reduced TNF/3 production 
in PBC, since no association of the low responder allele 
was found for this disease (18). 
Current evidence indicates that T cells require costim- 
ulatory activity in addition to triggering of the TCR corn- 
plex for activation. Failure to provide sufficient costim- 
ulatory activity does not only prevent T-cell activation 
but instead results in a prolonged unresponsive State 
(N-21). The unresponsiveness in these cells is primarily 
the result of insufficient lymphokine secretion, particu- 
larly that of IL2 (21,22). In PBC, neo-expression of 
MHC class II antigens can be detected on biliary epithe- 
lial cells (23,24) which may thereby qualify for antigen 
presentation and triggering of the TCR complex. Since 
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these non-professional antigen presenting cells provide 
only little costimulatory activity (25,26), it is an intrigu- 
ing speculation that in PBC the unresponsiveness of T 
lymphocytes with regard to TNFj3, TNFa, and IFNy 
production might be the result of prior contact with pa- 
renchymal cells aberrantly expressing MHC class II mol- 
ecules. As aberrant MHC class II expression is most 
prominent in the beginning of PBC (30), a considerably 
larger fraction of cells might be unresponsive in T-cell 
lines from patients with early stages of the disease. 
Reduced production of IL2, IFNy, TNFa, and TNF/3 
has been reported in a variety of human autoimmune 
diseases and in experimental models of autoimmune dis- 
ease which are characterized by aberrant MHC class II 
expression (27-34). These experimental models further 
demonstrate that low levels of TNFa may be associated 
with tissue damage, whereas high amounts can exert 
protective effects (32). Replacement therapy with recom- 
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